Renal Associates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Renal associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Renal Associates Today - Breaking & Trending Today

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Satya Medicherla , Shalabh Gupta , European Renal Association , Shire International Licensing , Unicycive Therapeutics Inc , Reason Research , Exchange Commission , Company Or Unicycive , Moral Administration , Drug Administration , Renal Associates , Preclinical Model , Hyperphosphatemia Demonstrate , Relative Potency , Potential Candidate , Delayed Graft Function Related , Acute Kidney Injury , Chief Executive Officer , Enhanced Urinary Phosphorous Reduction , Comparative Study , Oxylanthanum Carbonate , Vice President , Preclinical Pharmacology , End Stage Kidney Disease ,

Study finds clinicians do not consistently use algorithms when dosing Mircera

LONG BEACH, Calif. — Clinicians do not consistently use algorithms for dosing methoxy polyethylene glycol-epoetin beta when treating patients with anemia, presented research shows.
“Multiple dosing algorithms exist for the use of [methoxy polyethylene glycol-epoetin beta] MPG-EPO [Mircera, Vifor Pharma],” Namrata Shrestha, MD, of the University of the Incarnate Word, San ....

United States , San Antonio , Gina Brockenbrough , Bymarke Neumann , Namrata Shrestha , Renal Associates , University Of The Incarnate Word , National Kidney Foundation Spring Clinical Meetings , Incarnate Word , National Kidney Foundation Spring Clinical ,

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Laguna Beach , Alexander Dobranowski , Pardeeps Sangha , Healwell Ai Inc , National Kidney Foundation , Toronto Stock Exchange , National Library Of Medicine , Electronic Health Record , Khure Clinical Co , Ai Clinical Co , Klinrisk Inc , Health Technologies Corp , Electronic Health Records , Heawell Ai Clinical Co , Health Of Canadians , Renal Associates , Khure Health , Globe Newswire Healwell Ai Inc , Chronic Kidney Disease , American Journal , Kidney Diseases , Clinical Co Pilot , North American , Early Results From The Gemini Rapa Project , With Risk Prediction And Personalized ,

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

LOS ALTOS, Calif., March 25, 2024 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that multiple presentations will be delivered on the Company’s product candidates, oxylanthanum carbonate (OLC) and UNI-494, at the 61st European Renal Association (ERA) Congress taking place May 23-26, 2024, in Stockholm, Sweden. Shalabh Gupta, MD, Chief Execu ....

United States , United Kingdom , Satya Medicherla , Shalabh Gupta , Exchange Commission , European Renal Association , Drug Administration , Unicycive Therapeutics Inc , Company Or Unicycive , Reason Research , Shire International Licensing , Renal Associates , Moral Administration , Chief Executive Officer , Urinary Phosphorous Reduction , Comparative Study , Oxylanthanum Carbonate , Vice President , Preclinical Pharmacology , End Stage Kidney Disease , Tolerability Trial , Acute Kidney Injury , Rat Model , Delayed Graft , End Stage Renal Disease , Delayed Graft Function ,

Ziltivekimab Improves Anemia Parameters in Patients With CKD

Together with previous research, this analysis suggests a new therapeutic approach for treating anemia in the CKD population. Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease (CKD). ....

San Antonio , United States , Journal Of The American Society Nephrology , Renal Associates , American Society ,